Search
 

Karen E. Keller Attorney

Partner at Shaw Keller LLP
Wilmington, US
k...@...ler.com (Login to view more)
Practice Areas: Patent Litigation, Intellectual Property
(302) ???-???? (Login to view more)

LitigationSubscription-Only

N/A
Cases (Past 5 years)
N/A
Defendant
N/A
Plaintiff
N/A
Other

Date
Case numberTypeClientFirm
Jan 30, 2019 1:19-cv-00194 Defendant QVC, Inc.Shaw Keller LLP
Jan 30, 2019 1:19-cv-00193 Defendant HSNi, LLCShaw Keller LLP
Jan 28, 2019 1:19-cv-00149 Counter Defendant, Plaintiff ABBOTT CARDIOVASCULAR SYSTEMS INC., Evalve, Inc.Shaw Keller LLP
Jan 25, 2019 1:19-cv-00140 Plaintiff Hodei Technology, LLCShaw Keller LLP
Jan 25, 2019 1:19-cv-00145 Defendant Digital Store LLC, Shudder LLC, IFC TV LLC, WE TV LLC, SundanceTV LLC, AMC Premiere LLC, IFC In Theaters LLC, AMC Networks Inc.Shaw Keller LLP
Jan 25, 2019 1:19-cv-00146 Defendant Paramount Streaming, Showtime Networks Inc., Showtime Digital Inc.Shaw Keller LLP
Jan 25, 2019 1:19-cv-00147 Defendant The CW Network, LLCShaw Keller LLP
Jan 9, 2019 1:19-cv-00053 Defendant Teva PharmaceuticalsShaw Keller LLP
Jan 2, 2019 1:19-cv-00005 Defendant Intuitive SurgicalShaw Keller LLP
Dec 27, 2018 1:18-cv-02054 Defendant Banner Life Sciences LLCShaw Keller LLP
Dec 19, 2018 1:18-cv-00226 Counter Claimant, Defendant Teva PharmaceuticalsShaw Keller LLP
Dec 19, 2018 1:18-cv-02012 Defendant Teva PharmaceuticalsShaw Keller LLP
Dec 17, 2018 1:18-cv-02000 Defendant Jive Communications, Inc.Shaw Keller LLP
Dec 11, 2018 1:18-cv-01949 Counter Defendant, Plaintiff Align Technology, Inc.Shaw Keller LLP
Dec 11, 2018 1:18-cv-01950 Plaintiff Align Technology, Inc.Shaw Keller LLP
Dec 11, 2018 1:18-cv-01953 Counter Defendant, Plaintiff Eagle Pharmaceuticals, Inc.Shaw Keller LLP
Dec 5, 2018 1:18-cv-01926 Counter Claimant, Defendant Teva PharmaceuticalsShaw Keller LLP
Nov 30, 2018 1:18-cv-01900 Defendant Teva PharmaceuticalsShaw Keller LLP
Nov 29, 2018 1:18-cv-01895 Defendant Teva Pharmaceuticals, Actavis Laboratories FLShaw Keller LLP
Nov 19, 2018 1:18-cv-01818 Defendant Xellia PharmaceuticalsShaw Keller LLP
Menu